Bessemer Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-40,748
Closed -$1.68M 113
2019
Q2
$1.68M Hold
40,748
0.7% 26
2019
Q1
$1.64M Hold
40,748
0.56% 30
2018
Q4
$1.69M Buy
+40,748
New +$1.69M 0.64% 27

Other funds holding PFE

Bessemer Securities's PFE Position: Q3 2019 in Review

Bessemer Securities sold out of Pfizer (PFE) in Q3 2019, closing a stake of 40,748 shares — an estimated $1.68M sold.

Bessemer Securities first reported a position in PFE in Q4 2018 and held it in 3 quarters. The position peaked at $1.69M in Q4 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Bessemer Securities reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • Bessemer Securities sold 40,748 Pfizer shares in Q3 2019, an estimated $1.68M.
  • Bessemer Securities first reported a position in Pfizer in Q4 2018 and held it in 3 quarters.
  • Bessemer Securities's Pfizer position peaked at $1.69M in Q4 2018.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Bessemer Securities's 13F filing for Q3 2019, filed 7 Nov 2019.